Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay N Cohn

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Circulation|November 6, 2013
The message is clear: prevent as well as treat acute myocardial infarctionJay N Cohn
American Journal of Hypertension|February 5, 2002
Hypertension therapeutic research: a plea for change in the new millenniumJay N Cohn
Nature Reviews. Cardiology|March 31, 2011
Pharmacotherapy: inhibiting LV remodeling—the need for a targeted approachJay N Cohn
Journal of the American College of Cardiology|August 19, 2007
Myocardial structural effects of aldosterone receptor antagonism in heart failureJay N Cohn
Advances in Therapy|January 1, 2008
Reducing cardiovascular risk by blockade of the renin-angiotensin-aldosterone systemJay N Cohn
Circulation|May 19, 2004
The James B. Herrick Award Lecture. 2003. Clinical research: whose agenda is it?Jay N Cohn
Circulation|July 1, 2004
Introduction to surrogate markersJay N Cohn
Hypertension (Dallas, Tex. : 1979)|March 19, 2002
Techniques for studying arterial elastic propertiesJay N Cohn
JACC. Heart Failure|July 17, 2017
The Paradox in Demonstrating Hydralazine-Nitrate EfficacyJay N Cohn
European Heart Journal|September 4, 2009
Inotropic therapy for heart failure: paradise lostJay N Cohn
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Circulation|November 6, 2013
The message is clear: prevent as well as treat acute myocardial infarctionJay N Cohn
American Journal of Hypertension|February 5, 2002
Hypertension therapeutic research: a plea for change in the new millenniumJay N Cohn
Nature Reviews. Cardiology|March 31, 2011
Pharmacotherapy: inhibiting LV remodeling—the need for a targeted approachJay N Cohn
Journal of the American College of Cardiology|August 19, 2007
Myocardial structural effects of aldosterone receptor antagonism in heart failureJay N Cohn
Advances in Therapy|January 1, 2008
Reducing cardiovascular risk by blockade of the renin-angiotensin-aldosterone systemJay N Cohn
Circulation|May 19, 2004
The James B. Herrick Award Lecture. 2003. Clinical research: whose agenda is it?Jay N Cohn
Circulation|July 1, 2004
Introduction to surrogate markersJay N Cohn
Hypertension (Dallas, Tex. : 1979)|March 19, 2002
Techniques for studying arterial elastic propertiesJay N Cohn
JACC. Heart Failure|July 17, 2017
The Paradox in Demonstrating Hydralazine-Nitrate EfficacyJay N Cohn
European Heart Journal|September 4, 2009
Inotropic therapy for heart failure: paradise lostJay N Cohn
Pageof 18